ArticleHuman vaccines & immunotherapeutics2023

Recurrent pleural effusion as a rare manifestation after prolonged PD1 inhibitor (camrelizumab)-based immunotherapy: A case report.

Xiao-Hong Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.